Advertisement
Advertisement

NSPR

NSPR logo

InspireMD, Inc.

0.80
USD
Sponsored
-0.02
-1.87%
Jun 09, 15:29 UTC -4
Open

NSPR Earnings Reports

Positive Surprise Ratio

NSPR beat 26 of 32 last estimates.

81%

Next Report

Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.41M
/
-$0.20
Implied change from Q1 26 (Revenue/ EPS)
-58.46%
/
+25.00%
Implied change from Q2 25 (Revenue/ EPS)
-20.60%
/
-23.08%

InspireMD, Inc. earnings per share and revenue

On May 04, 2026, NSPR reported earnings of -0.16 USD per share (EPS) for Q1 26, beating the estimate of -0.18 USD, resulting in a 12.85% surprise. Revenue reached 3.40 million, compared to an expected 2.76 million, with a 23.31% difference. The market reacted with a -5.98% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.20 USD, with revenue projected to reach 1.41 million USD, implying an increase of 25.00% EPS, and decrease of -58.46% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Autonomix Medical, Inc. Common Stock
Report Date
May 27, 2026 For Q4 26
Estimate
-$0.26
Actual
-$0.23
Surprise
+13.27%
logo
Mesa Laboratories Inc
Report Date
May 27, 2026 For Q4 26
Estimate
$0.34
Actual
-$0.75
Surprise
-316.26%
FAQ
For Q1 2026, InspireMD, Inc. reported EPS of -$0.16, beating estimates by 12.85%, and revenue of $3.40M, 23.31% above expectations.
The stock price moved down -5.98%, changed from $1.17 before the earnings release to $1.10 the day after.
The next earning report is scheduled for Aug 03, 2026.
Based on 4 analysts, InspireMD, Inc. is expected to report EPS of -$0.20 and revenue of $1.41M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement